CircSCAP interacts with SF3A3 to inhibit the malignance of non-small cell lung cancer by activating p53 signaling - Chen, Dongni; Zhou, Hongli; Cai, Zhuochen; Cai, Kaican; Liu, Ji; Wang, Weidong; Miao, Huikai; Li, Hongmu; Li, Rongzhen; Li, Xiaodong; Chen, Youfang; Wang, Hui-Yun; et al. (Journal of experimental & clinical cancer research, 2022)
Keywords: Analysis; Apoptosis; Biomarkers; Cancer therapies; Carcinoma, Non-Small-Cell Lung - genetics; Carcinoma, Non-Small-Cell Lung - pathology; Cell cycle; Cell Cycle Proteins - metabolism; Cell Proliferation - genetics; CircSCAP; Flow cytometry; Humans; Kinases; Lung cancer; Lung cancer, Non-small cell; Lung cancer, Small cell; Lung Neoplasms - pathology; Medical prognosis; MicroRNAs; MicroRNAs - genetics; Mutation; Non-small cell lung cancer; p53; Patients; Phosphorylation; Prognosis; Protein binding; Proto-Oncogene Proteins - metabolism; Ribonucleoprotein, U2 Small Nuclear - metabolism; RNA; RNA, Circular - genetics; SF3A3; Tumor proteins; Tumor Suppressor Protein p53 - genetics; China; United States--US; SF3A3; CircSCAP; Prognosis; Non-small cell lung cancer; p53